focus -WSS

focus

author：explore 2025-09-30 00:38:42 - browse：2

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices.

Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not. Right now, most people pay for it out of pocket. It runs about $950.

In general, Medicare covers FDA-approved medicines and medical devices that help diagnose or treat disease or injury. But there’s a catch for Grail: Medicare doesn’t cover tests that simply screen healthy people, as Galleri does.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： U.K. Biobank has 500,000 peoples' genome sequences available

WSS

ASCO Takeaways: Winners, snoozers, and the art of cancer care

U.K. Biobank has 500,000 peoples' genome sequences available

FDA investigates CAR

Finland to offer bird flu vaccine to select groups of people, a possible global first

Will the market for weight loss drugs really reach $100 billion?

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

hotspot

focus

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Cigna, Humana reportedly in talks to merge

After affirmative action ruling, medical educators look to 'holistic review'

Congress needs to close a vaccine

Anesthesiologist group: stop taking Ozempic before surgery

Takeda, Janssen join wearable maker to measure scratching

State Dept. review finds Biden bears some blame for Afghanistan failures

How to pay for weight loss drugs and save Medicare

In Memoriam: Notable people who died in 2023

How to pay for weight loss drugs and save Medicare

focus

STAT wants to know your pick for a great summer read or listen

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Will the market for weight loss drugs really reach $100 billion?

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Structure Therapeutics oral GLP

30 years of 'Listening to Prozac'

hotspot

explore

entertainment

leisure time